Home / News / World News / Article /
COVID-19: Donald Trump says testing 'not a problem,' but doubts persist
Updated On: 28 April, 2020 10:39 AM IST | Washington | AP
The new testing targets would ensure states had enough COVID-19 tests available to sample at least 2.6 per cent of their populations each month, a figure already met by a majority of states.

Donald Trump
The White House released new guidelines Monday aimed at answering criticism that America's coronavirus testing has been too slow, and President Donald Trump tried to pivot toward a focus on 'reopening' the nation. Still, there were doubts from public health experts that the White House's new testing targets were sufficient. Monday's developments were meant to fill critical gaps in White House plans to begin easing restrictions, ramping up testing for the virus while shifting the president's focus toward recovery from the economic collapse caused by the outbreak. The administration unveiled a 'blueprint' for states to scale up their testing in the coming week, a tacit admission, despite public statements to the contrary, that testing capacity and availability over the past two months have been lacking.
The new testing targets would ensure states had enough COVID-19 tests available to sample at least 2.6 per cent of their populations each month, a figure already met by a majority of states. Areas that have been harder hit by the virus would be able to test at double that rate, or higher, the White House said. The testing issue has bedeviled the administration for months. Trump told reporters on March 6 during a visit to the CDC in Atlanta that 'anybody that wants a test can get a test,' but the reality has proved to be vastly different. The initial COVID-19 test developed by the Centers for Disease Control and Prevention was contaminated, and early kits operated only on platforms able to perform a small number of test per day. While the rate of testing increased as tests developed for higher-capacity platforms, they were still limited by shortages of supplies, from nasal swabs to the reagents used to process the samples.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

